Potency assays for novel T-cell-inducing vaccines against malaria.

Potency assays for novel T-cell-inducing vaccines against malaria.

The complex life cycle of the malaria parasite involves several developmental stages in the mammalian host that provide opportunities for vaccine intervention. The effector arm of the immune response that protects against malaria is specific for each stage of the parasite life cycle. While CD4+ and...

Descripció completa

Dades bibliogràfiques
Autors principals:	Reyes-Sandoval, A, Pearson, F, Todryk, S, Ewer, K
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

Viral vector vaccines make memory T cells against malaria.
per: Reyes-Sandoval, A, et al.
Publicat: (2007)

Assaying the Potency of Influenza Vaccines
per: Philip D. Minor
Publicat: (2015-02-01)

Malaria vaccines: the stage we are at.
per: Todryk, S, et al.
Publicat: (2007)

Malaria vaccine development: lessons from the field.
per: Todryk, S, et al.
Publicat: (2009)

Development of a Cell-Based Reporter Potency Assay for Live Virus Vaccines
per: Dengyun Sun, et al.
Publicat: (2024-07-01)

Correction: Malaria vaccine development: Lessons from the field
per: Todryk, S, et al.
Publicat: (2011)

Assay of Diphtheria Vaccine Potency by Intradermal Challenge Test
per: E. I. Komarovskaya, et al.
Publicat: (2023-09-01)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.
per: Berthoud, T, et al.
Publicat: (2009)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
per: Keating, S, et al.
Publicat: (2005)

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials.
per: Berthoud, T, et al.
Publicat: (2009)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines (vol 340, pg 33, 2009)
per: Berthoud, T, et al.
Publicat: (2011)

Flu Titer on Chip®: A New Influenza Vaccine Potency Assay
Publicat: (2015-03-01)

A Novel High-Potency Tetanus Vaccine
per: Amanda Przedpelski, et al.
Publicat: (2020-08-01)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
per: Elias, S, et al.
Publicat: (2014)

Prime-boost vectored malaria vaccines: progress and prospects.
per: Hill, A, et al.
Publicat: (2010)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41]
per: Berthoud, T, et al.
Publicat: (2011)

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell
per: Stine Bangsgaard Hansen, et al.
Publicat: (2022-12-01)

A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
per: Ratanabanangkoon, K., et al.
Publicat: (2017)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
per: Pearson, FE
Publicat: (2011)

T Cell Memory to Vaccination
per: Stephen M. Todryk
Publicat: (2018-12-01)

Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines
per: Nisarg Patel, et al.
Publicat: (2023-07-01)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
per: Jesse Bodle, et al.
Publicat: (2023-03-01)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
per: Milicic, A, et al.
Publicat: (2017)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
per: Ewer (nee Russell), K, et al.
Publicat: (2018)

Unsymmetrical Bisquinolines with High Potency against <i>P. falciparum</i> Malaria
per: Katherine M. Liebman, et al.
Publicat: (2020-05-01)

Regulatory T cells limit the cellular response to CS and TRAP encoding candidate malaria vaccines in humans [MIM-SD-8756]
per: Dunachie, S, et al.
Publicat: (2005)

Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
per: Gautam Sanyal
Publicat: (2022-05-01)

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays
per: Xuanxuan Zhang, et al.
Publicat: (2023-12-01)

An in vitro T cell killing assay to assess new Plasmodium falciparum vaccine candidates
per: Longley, R, et al.
Publicat: (2013)

A novel in vitro potency assay of antisera against Thai Naja kaouthia based on nicotinic acetylcholine receptor binding
per: Kavi Ratanabanangkoon, et al.
Publicat: (2017-08-01)

Activation-induced markers detect vaccine-specific CD4⁺ T cell responses not measured by assays conventionally used in clinical trials
per: Bowyer, G, et al.
Publicat: (2018)

Vaccines against malaria
per: Hill, A
Publicat: (2011)

Vaccines against malaria.
per: Hill, A
Publicat: (2011)

CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay
per: Jing Zhou, et al.
Publicat: (2017-07-01)

In vitro immunotherapy potency assays using real-time cell analysis.
per: Fabio Cerignoli, et al.
Publicat: (2018-01-01)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
per: Anita Milicic, et al.
Publicat: (2017-08-01)

Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay
per: Farwah Iqbal, et al.
Publicat: (2017-08-01)

Finding the potency in planarians
per: Bret J. Pearson
Publicat: (2022-09-01)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41] (DOI:10.1016/j.jim.2008.09.021)
per: Berthoud, T, et al.
Publicat: (2011)

Bananas decrease acetaminophen potency in in vitro assays.
per: Yoshihiro Uesawa, et al.
Publicat: (2018-01-01)